New Molecular Targets in the Treatment of NSCLC

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|30|5333-5343

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.30, 2013-09, pp. : 5333-5343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MET and ALK as Targets for the Treatment of NSCLC

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3914-3932

Bentham Science Publishers

Access to resources Recommend Favorite

New Molecular Targets for Treatment of Peptic Ulcer Disease

By Lehmann F.S.  

Drugs, Vol. 63, Iss. 17, 2003-01 ,pp. : 1785-1797

Adis International

Access to resources Recommend Favorite

Potential New Anticancer Molecular Targets for the Treatment of Human Testicular Seminomas

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-10 ,pp. : 1075-1081

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 10, 2004-04 ,pp. : 1083-1091

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral Agents for Influenza: Molecular Targets, Concerns of Resistance, and New Treatment Options

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1041-1048

Bentham Science Publishers

Access to resources Recommend Favorite